tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Atara Biotherapeutics announces FDA acceptance of tabelecleucel BLA
PremiumThe FlyAtara Biotherapeutics announces FDA acceptance of tabelecleucel BLA
3M ago
Atara Biotherapeutics announces FDA acceptance of BLA for tabelecleucel
Premium
The Fly
Atara Biotherapeutics announces FDA acceptance of BLA for tabelecleucel
3M ago
Atara Biotherapeutics: Strategic Advancements and Financial Stability Support Buy Rating
Premium
Ratings
Atara Biotherapeutics: Strategic Advancements and Financial Stability Support Buy Rating
4M ago
Atara Biotherapeutics Announces $16M Stock Offering
PremiumCompany AnnouncementsAtara Biotherapeutics Announces $16M Stock Offering
6M ago
Buy Rating for Atara Biotherapeutics: Strategic Focus and Financial Positioning Ahead of Key FDA Meeting
Premium
Ratings
Buy Rating for Atara Biotherapeutics: Strategic Focus and Financial Positioning Ahead of Key FDA Meeting
6M ago
Atara Biotherapeutics Appoints New Board Members Amid Restructuring
Premium
Company Announcements
Atara Biotherapeutics Appoints New Board Members Amid Restructuring
6M ago
Atara Biotherapeutics Announces CFO Departure and New Appointment
PremiumCompany AnnouncementsAtara Biotherapeutics Announces CFO Departure and New Appointment
7M ago
Atara Biotherapeutics: Strategic Focus on Ebvallo BLA Resubmission and Market Position Enhancement
Premium
Ratings
Atara Biotherapeutics: Strategic Focus on Ebvallo BLA Resubmission and Market Position Enhancement
8M ago
Atara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor Outcomes
Premium
Company Announcements
Atara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor Outcomes
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100